166 related articles for article (PubMed ID: 34003918)
1. Color Fundus Autofluorescence to Determine Activity of Macular Neovascularization in Age-Related Macular Degeneration.
Vujosevic S; Toma C; Sarao V; Veritti D; Brambilla M; Muraca A; De Cillà S; Villani E; Nucci P; Lanzetta P
Transl Vis Sci Technol; 2021 Feb; 10(2):33. PubMed ID: 34003918
[TBL] [Abstract][Full Text] [Related]
2. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
3. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Optical Coherence Tomography Detection of New Neovascular Branches and Association With Exudation Recurrence in Neovascular Age-Related Macular Degeneration.
Arrigo A; Aragona E; Del Fabbro S; Balduzzi E; Parodi MB; Bandello F
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):30. PubMed ID: 38899961
[TBL] [Abstract][Full Text] [Related]
5. Green emission fluorophores in eyes with atrophic age-related macular degeneration: a colour fundus autofluorescence pilot study.
Borrelli E; Lei J; Balasubramanian S; Uji A; Cozzi M; Sarao V; Lanzetta P; Staurenghi G; Sadda SR
Br J Ophthalmol; 2018 Jun; 102(6):827-832. PubMed ID: 28972030
[TBL] [Abstract][Full Text] [Related]
6. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
7. Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population.
Kim JH; Kim JW; Kim CG
J Ocul Pharmacol Ther; 2022 Apr; 38(3):261-268. PubMed ID: 35119292
[No Abstract] [Full Text] [Related]
8. Exudative non-neovascular age-related macular degeneration.
Bacci T; Essilfie JO; Leong BCS; Freund KB
Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1123-1134. PubMed ID: 33242167
[TBL] [Abstract][Full Text] [Related]
9. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
[TBL] [Abstract][Full Text] [Related]
10. Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration: A Clinicopathologic Correlation.
Chen L; Messinger JD; Sloan KR; Swain TA; Sugiura Y; Yannuzzi LA; Curcio CA; Freund KB
Ophthalmology; 2020 Jul; 127(7):931-947. PubMed ID: 32247535
[TBL] [Abstract][Full Text] [Related]
11. Non-neovascular age-related macular degeneration with subretinal fluid.
Hilely A; Au A; Freund KB; Loewenstein A; Souied EH; Zur D; Sacconi R; Borrelli E; Peiretti E; Iovino C; Sugiura Y; Ellabban AA; Monés J; Waheed NK; Ozdek S; Yalinbas D; Thiele S; de Moura Mendonça LS; Lee MY; Lee WK; Turcotte P; Capuano V; Filali Ansary M; Chakravarthy U; Lommatzsch A; Gunnemann F; Pauleikhoff D; Ip MS; Querques G; Holz FG; Spaide RF; Sadda S; Sarraf D
Br J Ophthalmol; 2021 Oct; 105(10):1415-1420. PubMed ID: 32920528
[TBL] [Abstract][Full Text] [Related]
12. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETER VARIATIONS AFTER TREATMENT OF MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Parodi MB
Retina; 2021 Jul; 41(7):1463-1469. PubMed ID: 33315820
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of macular neovascularisation in geographic atrophy.
Sacconi R; Brambati M; Miere A; Costanzo E; Capuano V; Borrelli E; Battista M; Parravano M; Souied EH; Bandello F; Querques G
Br J Ophthalmol; 2022 Sep; 106(9):1282-1287. PubMed ID: 33836986
[TBL] [Abstract][Full Text] [Related]
14. Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning.
Schranz M; Told R; Hacker V; Reiter GS; Reumueller A; Vogl WD; Bogunovic H; Sacu S; Schmidt-Erfurth U; Roberts PK
Acta Ophthalmol; 2023 Feb; 101(1):e95-e105. PubMed ID: 35912717
[TBL] [Abstract][Full Text] [Related]
15. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
[TBL] [Abstract][Full Text] [Related]
16. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
17. Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration.
Ahmed D; Stattin M; Haas AM; Graf A; Krepler K; Ansari-Shahrezaei S
BMC Ophthalmol; 2020 Sep; 20(1):381. PubMed ID: 32977799
[TBL] [Abstract][Full Text] [Related]
18. [Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration].
Budzinskaya MV; Shelankova AV; Andreeva AA; Plyukhova AA; Afanasyeva MA
Vestn Oftalmol; 2021; 137(5):7-13. PubMed ID: 34726852
[TBL] [Abstract][Full Text] [Related]
19. Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Finn AP; Pistilli M; Tai V; Daniel E; Ying GS; Maguire MG; Grunwald JE; Martin DF; Jaffe GJ; Toth CA;
Am J Ophthalmol; 2021 Mar; 223():338-347. PubMed ID: 33221285
[TBL] [Abstract][Full Text] [Related]
20. OCTA Biomarker Search in Patients with nAMD: Influence of Retinal Fluid on Time-Dependent Biomarker Response.
Told R; Reumueller A; Schranz M; Brugger J; Weigert G; Reiter GS; Sacu S; Schmidt-Erfurth U
Curr Eye Res; 2023 Jun; 48(6):600-604. PubMed ID: 36891909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
